NAVCO Pharmaceuticals Inc. (TSXV: NAV)
Health Care · Biotechnology · CA
CA$0.01
— today · 0.0% 1Y
NAVCO Pharmaceuticals Inc. (TSXV: NAV) operates in the Biotechnology industry within the Health Care sector. The company is valued at $200.86K.
Over the last twelve months the share price has gained 0.0%, trading between 0.01 and 0.01.
Tweenvest scores NAVCO Pharmaceuticals Inc. across four factors: quality 10/100, value 52/100. Its strongest factor is value.
NAV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $200.86K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 2.14
- 52-week high
- CA$0.01
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 57.07M
- Employees
- —
- Next earnings
- —
About NAVCO Pharmaceuticals Inc.
Navco Pharmaceuticals, Inc. engages in the manufacture and research of nano-technology products and materials. It uses Computerized Nano-meter Algorithms. The company was founded by Marek Jasinski on April 21, 2018 and is headquartered in Burlington, Canada.
- ISIN
- CA63942R1091
- Listed since
- Nov 8, 2018
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Chimeric Therapeutics LimitedASX: CHM | $246.44K | AU$— | — |
| Nextel Medical Corp.OTCPK: MAJI | $239.24K | $0.00 | -2.93% |
| WPD Pharmaceuticals Inc.CNSX: WBIO | $233.63K | CA$— | — |
| Beroni Group LimitedOTCPK: BNIG.F | $216.88K | $— | — |
| Endonovo Therapeutics, Inc.OTCPK: ENDV | $180.76K | $0.00 | +100.00% |
| Regen BioPharma, Inc.OTCPK: RGBP | $167.53K | $0.00 | -50.00% |
| Biosergen AB (publ)OM: BIOSGN | $142.46K | Skr0.50 | +3.77% |
| Oxurion NVENXTBR: OXUR | $126.66K | €0.00 | -33.33% |
Figures last refreshed Oct 18, 2026.